pI: 8.165 |
Length (AA): 670 |
MW (Da): 76087 |
Paralog Number:
0
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 54 | 2d8t (A) | 8 | 58 | 33.00 | 0.56 | 0.8 | 0.376012 | 0.82 |
9 | 51 | 2csy (A) | 14 | 55 | 36.00 | 0.63 | 0.62 | 0.273579 | 1.23 |
187 | 236 | 1llm (C) | 103 | 155 | 42.00 | 0.31 | 0.7 | 0.259027 | 1.46 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128373)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G62240 | RING/U-box domain-containing protein |
Arabidopsis thaliana | AT2G47090 | zinc ion binding/nucleic acid binding |
Brugia malayi | Bm1_01350 | RE33889p |
Candida albicans | CaO19.10953 | potential zinc ring finger protein similar to S. cerevisiae YDR266C |
Candida albicans | CaO19.3449 | potential zinc ring finger protein similar to S. cerevisiae YDR266C |
Caenorhabditis elegans | CELE_C52E12.1 | Protein C52E12.1 |
Dictyostelium discoideum | DDB_G0275581 | hypothetical protein |
Drosophila melanogaster | Dmel_CG11414 | CG11414 gene product from transcript CG11414-RA |
Entamoeba histolytica | EHI_020100 | hypothetical protein |
Giardia lamblia | GL50803_4343 | Zinc finger domain |
Homo sapiens | ENSG00000167962 | zinc finger protein 598 |
Leishmania braziliensis | LbrM.30.1350 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_301290.1 | Zinc finger, C3HC4 type (RING finger), putative |
Leishmania infantum | LinJ.30.1290 | hypothetical protein, conserved |
Leishmania major | LmjF.30.1230 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.29.1230 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_15469 | hypothetical protein |
Mus musculus | ENSMUSG00000041130 | zinc finger protein 598 |
Oryza sativa | 4327105 | Os01g0251200 |
Oryza sativa | 4338285 | Os05g0279400 |
Onchocerca volvulus | OVOC10144 | Zinc finger protein 598 homolog |
Saccharomyces cerevisiae | YDR266C | Hel2p |
Trypanosoma brucei gambiense | Tbg972.6.2480 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.6.2710 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_6_2160 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.509059.20 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_326460 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_388390 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_403790 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_045380 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_118120 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_021850 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.6.2710 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.2710 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.2710 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.6.2710 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.